EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudieOpen Access

Pulmonary Vein Isolation With Optimized Linear Ablation vs Pulmonary Vein Isolation Alone for Persistent AF

Caihua Sang, Qiang Liu, Yiwei Lai, Shijun Xia, Ruhong Jiang, Songnan Li, Qi Guo, Qifan Li, Mingyang Gao, Xueyuan Guo, Lihong Huang, Nian Liu und 28 weitere

JAMA · 04.02.2025 · 333 (5) · 381

DOI: 10.1001/jama.2024.24438 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA, erschienen am 04.02.2025. Verfasst von Caihua Sang und 39 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Ethanol, Pulmonary Veins. Die Arbeit wurde bisher 128-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Success rates of pulmonary vein isolation (PVI) are modest for persistent atrial fibrillation (AF). Additional linear ablation beyond PVI has not been proved superior to PVI alone in randomized trials. Ethanol infusion of the vein of Marshall (EIVOM) facilitates ablation at the mitral isthmus and may lead to improved effectiveness of a linear ablation strategy.

Objective

To determine whether linear ablation with radiofrequency energy combined with EIVOM added to PVI improves sinus rhythm maintenance compared with PVI alone in patients with persistent AF. Design, Setting, and Participants The PROMPT-AF trial is an investigator-initiated, multicenter, open-label, randomized trial involving 12 tertiary hospitals in China. A total of 498 patients aged 18 to 80 years, with AF persisting for more than 3 months, undergoing first-time AF ablation, were enrolled and randomized from August 27, 2021, to July 16, 2023.

Interventions

Patients were randomized to undergo PVI alone or PVI plus EIVOM and linear ablation (intervention). The latter group first underwent EIVOM, followed by PVI and linear ablation of the left atrial roof, mitral isthmus, and cavotricuspid isthmus. Main Outcomes and Measures The primary end point was freedom from any documented atrial arrhythmias lasting more than 30 seconds, without the use of antiarrhythmic drugs within 12 months. Secondary outcomes included freedom from atrial arrhythmia recurrence, AF, atrial arrhythmia recurrence after multiple procedures, and documented atrial tachycardia or atrial flutter with or without antiarrhythmic drugs; AF burden; and improvement in quality of life. Patients were monitored with wearable single-lead electrocardiographic (ECG) patches, worn for 24 hours a week, supplemented by symptom-triggered ECGs and Holter monitoring.

Results

Among 498 randomized patients, 495 (99.4%) were included in the primary analysis (mean age, 61.1 years [SD, 9.7] years, 361 male [72.9%]). After 12 months, 174 of 246 patients (70.7%) assigned to undergo PVI plus EIVOM and linear ablation and 153 of 249 patients (61.5%) assigned to undergo PVI alone remained free from atrial arrhythmias without taking antiarrhythmic drugs (hazard ratio, 0.73; 95% CI, 0.54-0.99, P = .045). The intervention effect was consistent across all prespecified subgroups. The comparison of secondary outcomes did not demonstrate significant results.

Conclusion

Among patients with persistent AF, linear ablation combined with EIVOM in addition to PVI significantly improved freedom from atrial arrhythmias within 12 months compared with PVI alone. Trial Registration ClinicalTrials.gov Identifier: NCT04497376

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCatheter AblationEthanolPulmonary VeinsAgedFemaleHumansMaleMiddle AgedRecurrenceTreatment OutcomeQuality of LifeIncidencePericarditisPericardial EffusionElectrocardiography

Substanzen

Ethanol

Autor:innen und Institutionen

  • Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
  • Department of Cardiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Cardiology, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Taizhou, China.
  • Department of Cardiology, Shandong Provincial Hospital, Shandong First Medical University, Jinan, China.
  • Department of Cardiology, Sun Yet-Sen Memorial Hospital, Sun Yet-Sen University, Guangzhou, China.
  • Department of Cardiology, First Affiliated Hospital, Nanjing Medical University, Nanjing, China.

Zitieren

APA

Sang, C., Liu, Q., Lai, Y., Xia, S., Jiang, R., Li, S., Guo, Q., Li, Q., Gao, M., Guo, X., Huang, L., Liu, N., Jiang, C., Zuo, S., Liu, X., Li, M., Ge, W., Song, S., Chen, L., …, & PROMPT-AF investigators (2025). Pulmonary Vein Isolation With Optimized Linear Ablation vs Pulmonary Vein Isolation Alone for Persistent AF. JAMA, 333(5), 381. https://doi.org/10.1001/jama.2024.24438

Vancouver

Sang C, Liu Q, Lai Y, Xia S, Jiang R, Li S, et al. Pulmonary Vein Isolation With Optimized Linear Ablation vs Pulmonary Vein Isolation Alone for Persistent AF. JAMA. 2025;333(5):381. doi:10.1001/jama.2024.24438

BibTeX
@article{Sang2025,
  author = {Sang, Caihua and Liu, Qiang and Lai, Yiwei and Xia, Shijun and Jiang, Ruhong and Li, Songnan and Guo, Qi and Li, Qifan and Gao, Mingyang and Guo, Xueyuan and Huang, Lihong and Liu, Nian and Jiang, Chenxi and Zuo, Song and Liu, Xiaoxia and Li, Mengmeng and Ge, Weili and Song, Shangming and Chen, Lianghua and Xie, Shuanglun and Zou, Jiangang and Chen, Ke and Liu, Xiangfei and Hu, Hesheng and Wang, Xinhua and Zhang, Jinlin and Wang, Zhaojun and Wang, Chi and He, Liu and Jiang, Chao and Tang, Ribo and Zhou, Ning and Wang, Yunlong and Long, Deyong and Du, Xin and Jiang, Chenyang and Macle, Laurent and Dong, Jianzeng and Ma, Changsheng and PROMPT-AF investigators, PROMPT-AF investigators},
  title = {Pulmonary Vein Isolation With Optimized Linear Ablation vs Pulmonary Vein Isolation Alone for Persistent AF},
  journal = {JAMA},
  year = {2025},
  volume = {333},
  number = {5},
  pages = {381},
  doi = {10.1001/jama.2024.24438}
}
Kostenlos starten →